Helena C Maltezou
Overview
Explore the profile of Helena C Maltezou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
176
Citations
2615
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Maltezou H, Papamichalopoulos N, Horefti E, Tseroni M, Karapanou A, Gamaletsou M, et al.
Int J Environ Res Public Health
. 2023 Apr;
20(8).
PMID: 37107716
Surfaces have been implicated in the transmission of pathogens in hospitals. This study aimed to assess the effectiveness of an usnic-acid-containing self-decontaminating coating in reducing microbial surface contamination in tertiary-care...
22.
Boufidou F, Hatziantoniou S, Theodoridou K, Maltezou H, Vasileiou K, Anastassopoulou C, et al.
Vaccines (Basel)
. 2023 Mar;
11(3).
PMID: 36992197
This study aimed at producing an updated assessment of the incidence of anaphylaxis associated with COVID-19 vaccines based on pharmacovigilance data. Anaphylactic reaction and anaphylactic shock data post-COVID-19-vaccination reported from...
23.
Maltezou H, Hatziantoniou S, Theodoridou K, Vasileiou K, Anastassopoulou C, Tsakris A
Vaccine
. 2023 Mar;
41(14):2382-2386.
PMID: 36872145
Aim: The present study aimed to estimate the anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents in Europe. Methods: We retrieved data on 371 anaphylaxis cases following mRNA...
24.
Ledda C, Rapisarda V, Maltezou H
Vaccine X
. 2023 Feb;
13:100275.
PMID: 36819213
Despite the initial optimistic projections from various countries and the evidence that vaccination against coronavirus disease 2019 (COVID-19) reduces the associated hospitalization rates and mortality, vaccine hesitancy and refusal among...
25.
Maltezou H, Basoulis D, Bonelis K, Gamaletsou M, Giannouchos T, Karantoni E, et al.
Vaccine
. 2023 Feb;
41(14):2343-2348.
PMID: 36740558
Aim: We estimated vaccine effectiveness (VE) of full (booster) vaccination against severe outcomes in hospitalized COVID-19 patients during the Delta and Omicron waves. Methods: The study extended from November 15,...
26.
Maltezou H, Horefti E, Papamichalopoulos N, Tseroni M, Ioannidis A, Angelakis E, et al.
Microorganisms
. 2022 Nov;
10(11).
PMID: 36422303
(1) Background: Surfaces have been implicated in the transmission of infections. We aimed to assess how effective an usnic-acid-containing self-decontaminating coating was on the surfaces of the Athens underground metro....
27.
Maltezou H, Gamaletsou M, Koukou D, Giannouchos T, Sourri F, Syrimi N, et al.
Vaccine
. 2022 Nov;
40(52):7660-7666.
PMID: 36372669
Aim: We assessed the impact of COVID-19 vaccination status and time elapsed since the last vaccine dose on morbidity and absenteeism among healthcare personnel (HCP) in the context of a...
28.
Maltezou H, Ledda C, Gagneux-Brunon A, Botelho-Nevers E
Vaccine
. 2022 Nov;
40(50):7167-7169.
PMID: 36344360
No abstract available.
29.
Maltezou H, Martinez-Jarreta B, Rapisarda V, Ledda C
Front Public Health
. 2022 Oct;
10:1022327.
PMID: 36211662
No abstract available.
30.
Papanikolopoulou A, Maltezou H, Stoupis A, Kalimeri D, Pavli A, Boufidou F, et al.
J Clin Med
. 2022 Sep;
11(18).
PMID: 36143064
Catheter-associated urinary tract infections (CAUTIs) are among the most common healthcare-associated infections. Urine catheters are often reservoirs of multidrug-resistant (MDR) bacteria and sources of pathogens transmission to other patients. The...